These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 24354793)

  • 1. IgG-mediated down-regulation of IgE bound to mast cells: a potential novel mechanism of allergen-specific desensitization.
    Uermösi C; Zabel F; Manolova V; Bauer M; Beerli RR; Senti G; Kündig TM; Saudan P; Bachmann MF
    Allergy; 2014 Mar; 69(3):338-47. PubMed ID: 24354793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of allergen-specific desensitization.
    Uermösi C; Beerli RR; Bauer M; Manolova V; Dietmeier K; Buser RB; Kündig TM; Saudan P; Bachmann MF
    J Allergy Clin Immunol; 2010 Aug; 126(2):375-83. PubMed ID: 20624641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An unexpected protective role of low-affinity allergen-specific IgG through the inhibitory receptor FcγRIIb.
    Zha L; Leoratti FMS; He L; Mohsen MO; Cragg M; Storni F; Vogel M; Bachmann MF
    J Allergy Clin Immunol; 2018 Nov; 142(5):1529-1536.e6. PubMed ID: 29391255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of mast cell degranulation through a dual-targeting tandem IgE-IgG Fc domain biologic engineered to bind with high affinity to FcγRIIb.
    Cemerski S; Chu SY; Moore GL; Muchhal US; Desjarlais JR; Szymkowski DE
    Immunol Lett; 2012 Mar; 143(1):34-43. PubMed ID: 22305932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergen-specific IgG antibody signaling through FcγRIIb promotes food tolerance.
    Burton OT; Tamayo JM; Stranks AJ; Koleoglou KJ; Oettgen HC
    J Allergy Clin Immunol; 2018 Jan; 141(1):189-201.e3. PubMed ID: 28479335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Several distinct properties of the IgE repertoire determine effector cell degranulation in response to allergen challenge.
    Christensen LH; Holm J; Lund G; Riise E; Lund K
    J Allergy Clin Immunol; 2008 Aug; 122(2):298-304. PubMed ID: 18572230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitization of skin mast cells with IgE antibodies to Culicoides allergens occurs frequently in clinically healthy horses.
    Wagner B; Miller WH; Erb HN; Lunn DP; Antczak DF
    Vet Immunol Immunopathol; 2009 Nov; 132(1):53-61. PubMed ID: 19836083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with purified natural and recombinant allergens induces mouse IgG1 antibodies that recognize similar epitopes as human IgE and inhibit the human IgE-allergen interaction and allergen-induced basophil degranulation.
    Vrtala S; Ball T; Spitzauer S; Pandjaitan B; Suphioglu C; Knox B; Sperr WR; Valent P; Kraft D; Valenta R
    J Immunol; 1998 Jun; 160(12):6137-44. PubMed ID: 9637531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allergen-Specific Antibodies Regulate Secondary Allergen-Specific Immune Responses.
    Eckl-Dorna J; Villazala-Merino S; Linhart B; Karaulov AV; Zhernov Y; Khaitov M; Niederberger-Leppin V; Valenta R
    Front Immunol; 2018; 9():3131. PubMed ID: 30705676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgE and IgG Antibodies as Regulators of Mast Cell and Basophil Functions in Food Allergy.
    Kanagaratham C; El Ansari YS; Lewis OL; Oettgen HC
    Front Immunol; 2020; 11():603050. PubMed ID: 33362785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.
    Möbs C; Ipsen H; Mayer L; Slotosch C; Petersen A; Würtzen PA; Hertl M; Pfützner W
    J Allergy Clin Immunol; 2012 Nov; 130(5):1108-1116.e6. PubMed ID: 23021882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-Specific Expression of the Low-Affinity IgG Receptor, FcγRIIb, on Human Mast Cells.
    Burton OT; Epp A; Fanny ME; Miller SJ; Stranks AJ; Teague JE; Clark RA; van de Rijn M; Oettgen HC
    Front Immunol; 2018; 9():1244. PubMed ID: 29928276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant allergen molecules: tools to study effector cell activation.
    Valenta R; Kraft D
    Immunol Rev; 2001 Feb; 179():119-27. PubMed ID: 11292015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of allergen-specific IgE reactivity by a human Ig Fcgamma-Fcepsilon bifunctional fusion protein.
    Zhang K; Kepley CL; Terada T; Zhu D; Perez H; Saxon A
    J Allergy Clin Immunol; 2004 Aug; 114(2):321-7. PubMed ID: 15316510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
    Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B
    Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergens displayed on virus-like particles are highly immunogenic but fail to activate human mast cells.
    Engeroff P; Caviezel F; Storni F; Thoms F; Vogel M; Bachmann MF
    Allergy; 2018 Feb; 73(2):341-349. PubMed ID: 28787769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with Hypoallergens of shrimp allergen tropomyosin inhibits shrimp tropomyosin specific IgE reactivity.
    Wai CY; Leung NY; Ho MH; Gershwin LJ; Shu SA; Leung PS; Chu KH
    PLoS One; 2014; 9(11):e111649. PubMed ID: 25365343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral immunotherapy induces IgG antibodies that act through FcγRIIb to suppress IgE-mediated hypersensitivity.
    Burton OT; Logsdon SL; Zhou JS; Medina-Tamayo J; Abdel-Gadir A; Noval Rivas M; Koleoglou KJ; Chatila TA; Schneider LC; Rachid R; Umetsu DT; Oettgen HC
    J Allergy Clin Immunol; 2014 Dec; 134(6):1310-1317.e6. PubMed ID: 25042981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A chimeric human-cat Fcgamma-Fel d1 fusion protein inhibits systemic, pulmonary, and cutaneous allergic reactivity to intratracheal challenge in mice sensitized to Fel d1, the major cat allergen.
    Terada T; Zhang K; Belperio J; Londhe V; Saxon A
    Clin Immunol; 2006 Jul; 120(1):45-56. PubMed ID: 16473552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy.
    Schmitz N; Dietmeier K; Bauer M; Maudrich M; Utzinger S; Muntwiler S; Saudan P; Bachmann MF
    J Exp Med; 2009 Aug; 206(9):1941-55. PubMed ID: 19667059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.